What is ANTX's dilution risk score?

ANTX has a latest available DilutionScore record of 71/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ANTX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ANTX?

DilutionWatch tracks 25 SEC filing types for ANTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ANTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ANTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ANTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ANTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ANTX Dilution Risk Score: 71/100 (HIGH)

Score Breakdown

📋 Offering Ability

100

💰 Cash Runway

65

📊 Float Risk

45

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 29%

💰 Capital Raise model 53%

• Under 12 months cash (10mo)

• Active shelf registration ($300M, 192% of market cap)

📉 Score Deterioration model 10%

• Score in HIGH risk zone (71/100)

🔔 Track ANTX — Get forecast alerts →

Market Data

Market Cap$155.95M

Shares Outstanding37.74M

Float17.02M

Cash$44.32M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 205.4% shares (2026Q1 vs prior)

52 institutional holders · 27.64M shares

#1 Vivo Capital, LLC 6.31M shares

#2 Commodore Capital LP 2.33M shares

#3 MILLENNIUM MANAGEMENT LLC 2.22M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.38M

Days to Cover14.8

% of Float14.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-06-30

xbrl XBRL CONVERTIBLE 2022-12-31

424B3 ATM 2026-04-20

424B5 ATM 2026-04-20

EFFECT EFFECT 2026-04-20

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ANTX Dilution Snapshot

AN2 Therapeutics, Inc. (ANTX) has a DilutionScore of 71/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $300.0M.
Stored ATM program remaining capacity: $80.0M.
Recent SEC activity tracked for ANTX: 424B3 on 2026-04-20; 424B5 on 2026-04-20; EFFECT on 2026-04-20.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.